Thrivent Financial for Lutherans’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,604
Closed -$288K 2423
2024
Q4
$288K Sell
15,604
-99
-0.6% -$1.93K ﹤0.01% 2420
2024
Q3
$341K Sell
15,703
-1,189
-7% -$26.6K ﹤0.01% 2359
2024
Q2
$331K Sell
16,892
-589
-3% -$12.3K ﹤0.01% 2358
2024
Q1
$379K Sell
17,481
-475
-3% -$11.8K ﹤0.01% 2311
2023
Q4
$519K Sell
17,956
-660
-4% -$17.7K ﹤0.01% 2197
2023
Q3
$498K Sell
18,616
-421
-2% -$14.4K ﹤0.01% 2137
2023
Q2
$705K Sell
19,037
-509
-3% -$17.7K ﹤0.01% 2023
2023
Q1
$610K Sell
19,546
-685
-3% -$22K ﹤0.01% 2042
2022
Q4
$602K Sell
20,231
-731
-3% -$26.2K ﹤0.01% 2034
2022
Q3
$799K Buy
20,962
+1,596
+8% +$80K ﹤0.01% 1820
2022
Q2
$1.06M Buy
19,366
+3,581
+23% +$197K ﹤0.01% 1681
2022
Q1
$985K Buy
15,785
+5
+0% +$329 ﹤0.01% 1838
2021
Q4
$1.59M Buy
15,780
+270
+2% +$23.7K ﹤0.01% 1554
2021
Q3
$1.4M Buy
15,510
+1,046
+7% +$95.1K ﹤0.01% 1609
2021
Q2
$1.33M Sell
14,464
-5
-0% -$399 ﹤0.01% 1664
2021
Q1
$1.4M Buy
14,469
+3,619
+33% +$374K ﹤0.01% 1652
2020
Q4
$565K Buy
10,850
+1,072
+11% +$44.8K ﹤0.01% 2079
2020
Q3
$392K Buy
+9,778
New +$306K ﹤0.01% 2081

Other funds holding FLGT

Thrivent Financial for Lutherans's FLGT Position: Q1 2025 in Review

Thrivent Financial for Lutherans sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 15,604 shares — an estimated $288K sold.

Thrivent Financial for Lutherans first reported a position in FLGT in Q3 2020 and held it in 18 quarters. The position peaked at $1.59M in Q4 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Thrivent Financial for Lutherans reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 15,604 Fulgent Genetics shares in Q1 2025, an estimated $288K.
  • Thrivent Financial for Lutherans first reported a position in Fulgent Genetics in Q3 2020 and held it in 18 quarters.
  • Thrivent Financial for Lutherans's Fulgent Genetics position peaked at $1.59M in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2025, filed 13 May 2025.